Time restricted EAting for Type 2 diabetes and MEtabolic health: The TEA TIME trial study protocol.
Matthew Retnakaran, Vittória L Lessa, Caroline K Kramer
https://pubmed.ncbi.nlm.nih.gov/41818195Actively Recruiting
Led by Mount Sinai Hospital, Canada · Updated on 2026-02-11
112
Participants Needed
1
Research Sites
17 weeks
Total Duration
Researchers are studying time-restricted eating as a potential way to preserve pancreatic beta-cell function and improve blood sugar control in people with type 2 diabetes. This randomized controlled trial focuses on adults who have been diagnosed with type 2 diabetes within the last 10 years and have a body mass index (BMI) over 25. The study aims to evaluate whether limiting eating to a certain time window each day can help with metabolic health and diabetes management. Participants will be randomly assigned to one of two groups. One group will follow a time-restricted eating plan where they fast for 18 hours each day and eat only during a 6-hour window from 2 to 8 PM for 52 weeks. The other group will follow standard lifestyle recommendations based on Diabetes Canada guidelines, which encourage regular meal timing but do not specify fasting periods. Both groups will be monitored throughout the year-long study. During the study, participants will undergo assessments to measure their insulin secretion and sensitivity, insulin resistance, and the amount of time their blood sugar stays within target ranges. These measures will be compared between the two groups after 52 weeks. Participants’ weight stability, medication use, and adherence to the assigned eating plan will be tracked. Safety and metabolic health will be monitored throughout the trial, which is expected to continue until July 2029.
CONDITIONS
Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 52 weeks
Participants follow either a time-restricted eating schedule with 18 hours of fasting and a 6-hour eating window daily or standard lifestyle recommendations for diabetes management.
Regular visits for dietary counseling and assessments
Total: 1 location
1
Leadership Sinai Centre for Diabetes
Toronto, Ontario, Canada, M5T3L9
Actively Recruiting
C
Caroline K Kramer, MD, PhD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Matthew Retnakaran, Vittória L Lessa, Caroline K Kramer
https://pubmed.ncbi.nlm.nih.gov/41818195